This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Kamat SA, Rajagopalan K, Stephenson JJ, Agarwal S.The impact of natalizumab on patient-reported outcomes in a critical practice setting: a cross-sectional survey. The Patient - Patient-Centered Outcomes Research 2: 105-112, No. 2, 1 Jan 2009
Rights and permissions
About this article
Cite this article
Natalizumab for MS improves QOL in the clinical setting. Pharmacoecon. Outcomes News 581, 9 (2009). https://doi.org/10.2165/00151234-200905810-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905810-00027